Results

Reset All Filters

Manufacturer:Adooq remove filter

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Item no.	Amount	Price
B220 50mg	Inhibitors	Other	A20391-50 Adooq	50 mg	Login Compare	B220 50mg
PARP-2-IN-1 25mg	Inhibitors	Other	A20240-25 Adooq	25 mg	Login Compare	PARP-2-IN-1 25mg
PARP-2-IN-1 50mg	Inhibitors	Other	A20240-50 Adooq	50 mg	Login Compare	PARP-2-IN-1 50mg
PARP-2-IN-1 100mg	Inhibitors	Other	A20240-100 Adooq	100 mg	Login Compare	PARP-2-IN-1 100mg
Zabofloxacin 50mg	Inhibitors	Other	A20246-50 Adooq	50 mg	Login Compare	Zabofloxacin 50mg
Complement factor D-IN-1 25mg	Inhibitors	Other	A20253-25 Adooq	25 mg	Login Compare	Complement factor D-IN-1 25mg
Complement factor D-IN-1 10mM * 1mL in DMSO	Inhibitors	Other	A20253-10mM-D Adooq	10mM x 1mL in DMSO	Login Compare	Complement factor D-IN-1 10mM * 1mL in DMSO
Nelociguat 5mg	Inhibitors	Other	A20591-5 Adooq	5 mg	Login Compare	Nelociguat 5mg
Nelociguat 10mg	Inhibitors	Other	A20591-10 Adooq	10 mg	Login Compare	Nelociguat 10mg
Nelociguat 50mg	Inhibitors	Other	A20591-50 Adooq	50 mg	Login Compare	Nelociguat 50mg
Nelociguat 100mg	Inhibitors	Other	A20591-100 Adooq	100 mg	Login Compare	Nelociguat 100mg
PROTAC BET-binding moiety 2 5mg	Inhibitors	Other	A20655-5 Adooq	5 mg	Login Compare	PROTAC BET-binding moiety 2 5mg
PROTAC BET-binding moiety 2 10mg	Inhibitors	Other	A20655-10 Adooq	10 mg	Login Compare	PROTAC BET-binding moiety 2 10mg
PROTAC BET-binding moiety 2 50mg	Inhibitors	Other	A20655-50 Adooq	50 mg	Login Compare	PROTAC BET-binding moiety 2 50mg
PROTAC BET-binding moiety 2 100mg	Inhibitors	Other	A20655-100 Adooq	100 mg	Login Compare	PROTAC BET-binding moiety 2 100mg
Fumarate hydratase-IN-1 2mg	Inhibitors	Other	A20471-2 Adooq	2 mg	Login Compare	Fumarate hydratase-IN-1 2mg
Fumarate hydratase-IN-1 5mg	Inhibitors	Other	A20471-5 Adooq	5 mg	Login Compare	Fumarate hydratase-IN-1 5mg
Fumarate hydratase-IN-1 10mg	Inhibitors	Other	A20471-10 Adooq	10 mg	Login Compare	Fumarate hydratase-IN-1 10mg
Fumarate hydratase-IN-1 50mg	Inhibitors	Other	A20471-50 Adooq	50 mg	Login Compare	Fumarate hydratase-IN-1 50mg
UKI-1 1mg	Inhibitors	Other	A20516-1 Adooq	1 mg	Login Compare	UKI-1 1mg
UKI-1 5mg	Inhibitors	Other	A20516-5 Adooq	5 mg	Login Compare	UKI-1 5mg
UKI-1 10mg	Inhibitors	Other	A20516-10 Adooq	10 mg	Login Compare	UKI-1 10mg
UKI-1 50mg	Inhibitors	Other	A20516-50 Adooq	50 mg	Login Compare	UKI-1 50mg
B220 25mg	Inhibitors	Other	A20391-25 Adooq	25 mg	Login Compare	B220 25mg
B220 100mg	Inhibitors	Other	A20391-100 Adooq	100 mg	Login Compare	B220 100mg

Name Price

B220 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20391-50
Amount	50 mg
Available

PARP-2-IN-1 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20240-25
Amount	25 mg
Available

PARP-2-IN-1 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20240-50
Amount	50 mg
Available

PARP-2-IN-1 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20240-100
Amount	100 mg
Available

Zabofloxacin 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20246-50
Amount	50 mg
Available

Complement factor D-IN-1 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20253-25
Amount	25 mg
Available

Complement factor D-IN-1 10mM * 1mL in DMSO

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20253-10mM-D
Amount	10mM x 1mL in DMSO
Available

Nelociguat 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20591-5
Amount	5 mg
Available

Nelociguat 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20591-10
Amount	10 mg
Available

Nelociguat 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20591-50
Amount	50 mg
Available

Nelociguat 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20591-100
Amount	100 mg
Available

PROTAC BET-binding moiety 2 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20655-5
Amount	5 mg
Available

PROTAC BET-binding moiety 2 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20655-10
Amount	10 mg
Available

PROTAC BET-binding moiety 2 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20655-50
Amount	50 mg
Available

PROTAC BET-binding moiety 2 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20655-100
Amount	100 mg
Available

Fumarate hydratase-IN-1 2mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20471-2
Amount	2 mg
Available

Fumarate hydratase-IN-1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20471-5
Amount	5 mg
Available

Fumarate hydratase-IN-1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20471-10
Amount	10 mg
Available

Fumarate hydratase-IN-1 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20471-50
Amount	50 mg
Available

UKI-1 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20516-1
Amount	1 mg
Available

UKI-1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20516-5
Amount	5 mg
Available

UKI-1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20516-10
Amount	10 mg
Available

UKI-1 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20516-50
Amount	50 mg
Available

B220 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20391-25
Amount	25 mg
Available

B220 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20391-100
Amount	100 mg
Available

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk